Las Vegas, NV -- (SBWIRE) -- 01/22/2013 -- INTELLICELL BIOSCI (PINK:SVFC) has reported that recently they have received a notice of allowance for its US patent application that was titled "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells.". This technology is an innovative way to separate the stromal vascular fraction from the fat layer without using enzymes. The company management is very excited about their allowance and they believe it to be significant move toward the regenerative medical technology.
Intellicell Biosciences Inc has the US patents for the safe use of ultrasonic for diagnosis, treatment and cure for decades. Now the license for IntelliSonic developed by intelliCell will contribute more toward better cure by the production of least manipulated therapeutically active regenerative autologous cell. INTELLICELL BIOSCI has many applications pending for approval by US patent authorities.
The company is planning to work with multi-disciplinary medical specialists for efficient use of this technology. IntelliCell, based in New York is running multiple projects with universities for better cure of Sclerosis, gum regeneration and osteoarthritis.
To find out what OTCMAGIC projects for Intellicell Biosciences Inc for both short term and long term please click here: SVFC
OTCMAGIC Spends all day scouring the markets for the next huge Stock Picks. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in hot stocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)